MedPath

Immune pathogenesis of tick-borne encephalitis virus

Recruiting
Conditions
A84.1
Central European tick-borne encephalitis
Registration Number
DRKS00017599
Lead Sponsor
Tierärztliche Hochschule Hannover
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

TBE disease within the last 3 years.

Exclusion Criteria

Non-consenting adults, children.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The immunological parameters of innate and acquired immunity will be examined for their quantity, quality and specificity. The anaysis is carried out after ontime blood sampling. For this purpose, the production of defense molecules by blood immune cells are measured by laboratory tests such as ELISA and flow cytometry and serum antibodies are analysed and quantified.
Secondary Outcome Measures
NameTimeMethod
At the time of blood sampling, the disease process is queried in a questionnaire in order to potentially correlate the course of the disease with the results of the laboratory tests. In addition, immune cells from the sampled blood are also being screened for possible gene alterations that may affect the immune system of TBE patients.
© Copyright 2025. All Rights Reserved by MedPath